SCHEMBL19082463

SCHEMBL19082463

c1cc(-c2cccc3ccccc23)cc(-c2c3ccccc3c(-c3ccc4oc5c(ccc6c5oc5ccc7ccccc7c56)c4c3)c3ccccc23)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.40
AHR P35869 3/20 0.38
CYP1A2 P05177 2/20 0.38
PAX8 Q06710 2/20 0.38
CYP1A1 P04798 1/20 0.38
FYN P06241 1/20 0.38
MAPK3 P27361 1/20 0.38
ABCG2 Q9UNQ0 1/20 0.38
MAPT P10636 6/20 0.36
HSD17B10 Q99714 6/20 0.36
ALDH1A1 P00352 5/20 0.36
HPGD P15428 5/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
KDM4E B2RXH2 5/20 0.36
TSHR P16473 3/20 0.36
ALOX15 P16050 1/20 0.36
CASP1 P29466 1/20 0.36
CASP7 P55210 1/20 0.36
TDP1 Q9NUW8 4/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081443 0.93 ALOX5 (0.39) ALOX5AHRCYP1A2PAX8CYP1A1
SCHEMBL19081644 0.92 ALOX5 (0.40) ALOX5AHRCYP1A2PAX8CYP1A1
SCHEMBL10122393 0.91 ALOX5 (0.48) ALOX5CYP1A2MAPTHSD17B10ALDH1A1
SCHEMBL16067849 0.91 ALOX5 (0.42) ALOX5CYP1A2CYP1A1ABCG2MAPT
SCHEMBL10122440 0.90 ALOX5 (0.47) ALOX5CYP1A2MAPTHSD17B10ALDH1A1
SCHEMBL24340949 0.89 ALOX5 (0.44) ALOX5AHRCYP1A2PAX8CYP1A1
SCHEMBL19081659 0.89 ALOX5 (0.36) ALOX5AHRCYP1A2PAX8CYP1A1
SCHEMBL10122643 0.89 ALOX5 (0.46) ALOX5CYP1A2MAPTHSD17B10ALDH1A1
SCHEMBL10122508 0.89 AHR (0.42) AHRCYP1A2PAX8CYP1A1FYN
SCHEMBL22063401 0.88 ALOX5 (0.40) ALOX5CYP1A2CYP1A1ABCG2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 ALOX5 1939/4885AHR 2453/4885CYP1A2 659/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 ALOX5 1939/4885AHR 2453/4885CYP1A2 659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.